Kukuvitis A, Deal C, Arbour L, Polychronakos C
Montreal Children's Hospital Research Institute, Department of Pediatrics, Quebec, Canada.
J Clin Endocrinol Metab. 1997 Apr;82(4):1192-4. doi: 10.1210/jcem.82.4.3904.
Persistent hyperinsulinemic hypoglycemia of infancy (PHHI), a rare disorder due to defective negative feedback regulation of insulin secretion by low glucose levels, is often familial. Most cases are recessively inherited, and mutations of the sulfonylurea receptor gene (SUR) or the closely linked KIR6.2 gene have been found in several families. Both of these genes encode components of the potassium channels responsible for glucose-regulated insulin release. However, in some families recessive PHHI is not linked to the SUR-KIR6.2 locus, suggesting genetic heterogeneity. We report here a French Canadian kindred with hypoglycemia in five first cousins. All five patients had documented hypoglycemia, and all responded well to diazoxide. In two, inappropriately elevated insulin levels during hypoglycemia were documented. This familial clustering strongly suggests the existence of an autosomal dominant form of PHHI. By preliminary linkage analysis, we tested the possibility of a dominant negative SUR or KIR6.2 mutant. The insulin (INS) and glucokinase (GCK) genes were also tested as additional candidates. Microsatellite markers closely linked to each gene were used, and large negative Lod scores were obtained at the known recombination fractions between all three genes studied and the corresponding marker. We conclude that mutation of a gene other than SUR or KIR6.2 is responsible for the dominant PHHI in this family, and this gene cannot be INS or GCK. We propose that a genome-wide search for this gene is important for elucidating this rare disorder and, more importantly, for determining its potential impact on understanding noninsulin-dependent diabetes mellitus and on the effort to develop bioengineered beta-cells for transplantation.
婴儿持续性高胰岛素血症性低血糖症(PHHI)是一种罕见的疾病,由于低血糖水平对胰岛素分泌的负反馈调节存在缺陷,常具有家族性。大多数病例为隐性遗传,在几个家族中发现了磺脲类受体基因(SUR)或紧密连锁的KIR6.2基因的突变。这两个基因均编码负责葡萄糖调节胰岛素释放的钾通道成分。然而,在一些家族中,隐性PHHI与SUR-KIR6.2基因座无关,提示存在遗传异质性。我们在此报告一个法裔加拿大亲属家族,其五名一级表亲患有低血糖症。所有五名患者均有低血糖记录,且对二氮嗪反应良好。其中两名患者在低血糖期间记录到胰岛素水平异常升高。这种家族聚集强烈提示存在常染色体显性形式的PHHI。通过初步连锁分析,我们测试了显性负性SUR或KIR6.2突变体的可能性。胰岛素(INS)和葡萄糖激酶(GCK)基因也作为额外的候选基因进行了测试。使用了与每个基因紧密连锁的微卫星标记,在研究的所有三个基因与相应标记之间的已知重组率处获得了较大的负对数优势分数。我们得出结论,该家族中显性PHHI是由SUR或KIR6.2以外的基因的突变引起的,且该基因不可能是INS或GCK。我们提出,对该基因进行全基因组搜索对于阐明这种罕见疾病很重要,更重要的是,对于确定其对理解非胰岛素依赖型糖尿病的潜在影响以及对开发用于移植的生物工程β细胞的努力具有重要意义。